Thus, the success of further study of the mutation spectrumof the LDLR gene will depend on several factors, one ofwhich is the formation of a complete nation-wide register ofpatients with FH, and the other is the introduction of targetedsequencing into routine practice. The gene discussed is LDLR; the disease is familial hyperaldosteronism.